Member Info for bignose58

Well, that certainly was interesting. 3 sells before lunch totalling 200k in shares. No change all day, then 5 mins before close the SP drops by nigh on 1.6%. Work that one out..... did some broker accidentally trip and fall on the "down" button.....again :-O

I asked the question, but had no response. Safe to say it will be included in the interim report in a couple of weeks.

https://www.google.com/url?rct=j&sa=t&url=https://www.ptcommunity.com/wire/mym-expands-scope-global-offices-include-sales-and-distribution-mym-international-brands-inc&ct=ga&cd=CAEYACoUMTM2NzQyODA0NzEyMzQyMTczODcyGjdhMzU4MTZkNmRhNTFiZDM6Y29tOmVuOlVT&usg=AFQjCNHaumLS_NJiYGQ5E6TeGyT6ulHrng

A brief mention by RPG....links ?

Keithbfk

Although painful, take some consolation its not like the sudden drop that has occurred for BUR over the last couple of days. Market cap dropped from 3.5bill to 1 bill......and all because some US company called "Muddy Watters" of all names, released a report effectively saying the company was worthless.

https://en.wikipedia.org/wiki/Muddy_Waters_Research

The.Italian

Something that was mentioned to me recently was the fact that If the loan notes have to be redeemed on a change of control of the company (see page 15 Redemption (iii) of the convertible notes announcement). Could RPG be repositioning themselves for such an event which may have collapsed before (hence no shares currently being placed)? If you remember RPG also hurriedly rushed through the share scheme immediately after the PLE TO, again since which no shares have ever been issued, why was/is that ?

There was always speculation on the sale of either PLE or the product, which, just maybe, due to the delays, as mentioned above, were put on ice due to there being too much optimism on timelines by RPG. We always had expectations of a US licensee being in place by now, but why not? Could it be that there is a certain interested party who are waiting in the wings on commencement or outcome of phase III, hence why there is still no news on North, Central or South America (The Americas) or even the Middle East which may also probably linked to the same licensee ??? (JG did indicate to me a few months back that the US licensee progress was dependant on the phase III process).

Although, again, only speculation. Maybe this time there is more meat on the bone in this regard, given the strange share jiggery pokery that has been going on ?

It will certainly be interesting to see what transpires over the next 6 to 12 months.

The.Italian.

Not wanting to have my post deleted, please take it as positive news from someone who knows a lot more about our own product than the resident troll.

So, if anyone is interested.

FDA timelines are indeed correct, If no unforeseen (or is that unforeskin) hiccups. Ironically (that was the word used....lol ) the phase III requires less participants., so I eat humble pie and give a thumbs up to JG for at least getting that one correct ..... :-)

And Recordati are still very much onboard with apparently a new sales push this Q3 once stocks have been replenished, which will to probably coincide with the expected launches.

Feeling much better now thank you very much......... LOL

Although nothing on the HK and Macau launches as yet.

The.Italian,

Thanks for the clarification. I actually thought, logically, that shares would be issued as monies were lent and expected new shares to hit the market for the 5.5mill usd already loaned and then whatever would be additionally loaned to go towards the Oz tax bill.

If it is as you have written and already suggested to me, it would make one think that there are reasons. i.e they expect some income to cover the loans or even buy back the shares in the next 3 years. I wonder what is going on ? I am sure we will all have a better understanding (or not) once the half yearly report is out in the next few weeks.

Seems I have that wrong too. Apparently I have been corrected again and none of the loan note shares will hit the market till the maturity date. Surprised no one posted here to put me right, so maybe everyone else was of the same thinking? Certainly means the drop is undeservedly way overdone given, as I posted before, we appear to have no included value for China or the FDA process. Certainly makes one wonder how the HK market makers work by lowering the sp over 13% this morning. But I'm sure someone here will put me straight on my simple thinking regarding that one... ;-)

Morning Heimdal,

I am sure it will, but probably not far given the expected dilution at 0.215 for the equivalent market cap at 0.25 when the announcement on dilution was made. Just depend on how many shares will initially be placed. My feeling is given the already loaned 5.5 mill USD and the monies required to pay the Ozzy tax bill probably in the region of 500 mill shares.

Any ideas when the initial shares are supposed to hit the market ?

A blood bath this morning.....dropped by more than 13%. currently SP 0.179HKD

Isn't Kim Eng now owned by Maybank ?

And I apologise on my first sentence. At less than 0.215, JG and the A team are at a slight loss....derrr. Honest gov I did get an A level in maffamatiks..... Lol

That should have been "disgustingly obscene salary" for more emphasis.... Lol.

Now below the placing price, so JG and the A team are in profit. They really should consider making a film ..... Lol.

And I'm sure it will edge lower since usually markets pay little attention to cash injections which are soon to be used up to pay such things as undeserved disgustingly high salaries and Legacy tax bills. It will all be based on what the market cap was before the shares hit the market. We are now at a price not seen by PLE shareholders since 6 or 7 years ago and that's now with 2 companies merged, a product which had a TO value of curca. 150mill USD, on sale for a year and 2 additional license agreements in place. WTF. Incompetent or what..... :-)

The.Italian.

I wasn't taking a shot at you. I was just agreeing with your statement. It seem to me they are now knowingly providing false information to shareholders old and new since it doesn't take anyone with half a brain to work out that phase II will take much longer than phase II. Are they deliberately making up dates to try and muster more interest and liquidity, especially with the ref to the CBD arena which they seem so desperate to enter.

I also remind you they stated they now had something more concrete following the Yooya fall-out, yet there was no mention of this earlier. It didn't just suddenly happen. So one is led to wonder if they are getting caught up in their own lies and have now lost all track of time ?

The.Italian,

You are giving them far too much credit........ Anyhoo, I was revisiting the operational update and I just cannot get my head round the statements:
"The Board is also pleased to report that the Phase II validation study of Fortacin™ in respect of the FDA approval process in the US is now estimated to complete by the end of 2019". And " On the assumption that the trial is sufficient to convince the FDA that the PEBEQ serves as an appropriate measure for support of a label claim, pivotal Phase III work could commence in Q1 of 2020, with NDA submission possible in the second half of 2020"

Correct me if I am wrong, but. Doesn't the phase III study require a lot more participants than the 100 used for phase II (yes indeed). Well, if its taken 12 months for the Phase II study to get to the point where they can convince......blah blah blah, surely for the phase III, where there will be a lot more participants, its surely pretty obvious that its going to take much more than the 10 or 11 months JG is alluding to before the NDA submission can be made (you notice he doesn't write late second half of 2020, but in the second half, which certainly can be considered as deliberately misleading, especially since they are meant to be the experts ?). Isnt it more likely to be at least 6 months to possibly a year longer than stated and that's only if we are lucky and all necessary participants come forward in haste ?

Of course, If I have missed something like maybe the 2014 unambiguous agreement with the FDA allows us to use the data from the EU, then I stand corrected........Ill eat my hat, but I am sure its not going to be that simple.

The.Italian,
Going by previous delays and management incompetence, which has clearly shown they couldn't manage to get themselves out of a browm paper bag, you may just be, but then again, we all may just be ..... Lol.

The.Italian,

I assume you also read the second part (part 1) ?
https://www.sciencedirect.com/science/article/pii/S2452302X1600036X

What I found interesting is: "Efforts include recent legislation in the U.S. Congress to facilitate release in the United States of drugs that have already achieved European approval", which makes sense since more than 20,000 EU users have applied the drug in over a year without any reports of dicks falling off or the growing of extra limbs....

Enjoy. ;-)

The.Italian

A bit of light reading....
https://www.sciencedirect.com/science/article/pii/S2452302X16300638